Torno Capital »

Crispr Therapeutics shares owned by Torno Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Torno Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $645k 10k 62.60

More positions owned by Torno Capital

Sprott Fds Tr Uranium Miners E Put Option (URNM)
Spotify Technology S A SHS Put Option (SPOT)
Alphabet Cap Stk Cl A (GOOGL)
Global X Fds Global X Uranium Put Option (URA)
Ishares Msci Sth Kor Etf Put Option (EWY)
Colgate-Palmolive Company Put Option (CL)
Caterpillar Call Option (CAT)
BlackRock Call Option (BLK)
Booz Allen Hamilton Hldg Cor Cl A Call Option (BAH)
United States Stl Corp New Com Put Option (X)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Incyte Corporation Call Option (INCY)
Realty Income Call Option (O)
Rio Tinto Sponsored Adr Call Option (RIO)
Regeneron Pharmaceuticals Put Option (REGN)

View all positions for Torno Capital

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
Citadel Advisors
Vanguard Group
NEA Management Company
Susquehanna International
Caption Management
Dimensional Fund Advisors
Bellevue Group
T. Rowe Price Associates
Bank of America Corporation
Voloridge Investment Management
Ikarian Capital

View all funds holding Crispr Therapeutics